Article Text

Download PDFPDF
437 Assesment of the quality of life of cervical cancer survivors on Brazilian Northeast
  1. Nathalia Moreira Ramalho1,
  2. Jurema telles De Oliveira Lima Sales2,
  3. Manoel Rodrigues De Andrade Neto3,
  4. Camilla Victoria Ribeiro Santana4,
  5. Ana Beatriz De Biase Bezerra De Melo4,
  6. Ana Lorena Nascimento Cordeiro4,
  7. João Pedro Carneiro De Oliveira4,
  8. Luís Henrique Rufino Amaral Pinheiro4,
  9. Maria Teresa Wallac Graciliano4,
  10. Candice Lima Santos5,
  11. Carla Rameri AS De Azevedo5,
  12. Andrezza Layane Alves Santos Paes De Barros6,
  13. Ana Luiza Fassizoli Da Fonte7 and
  14. Vandré Cabral Gomes Carneiro8
  1. 1IMIP/D’OR, Recife, Brazil
  2. 2IMIP/SES-PE/D’OR, Recife, Brazil
  3. 3IMIP/HBL/D’OR, Recife, Brazil
  4. 4FPS, Recife, Brazil
  5. 5IMIP/D’OR, Recife, Brazil
  6. 6IMIP/RHP, Recife, Brazil
  7. 7IMIP/HCP, Recife, Brazil
  8. 8IMIP/HCP/SES-PE HBL/D’OR, Recife, Brazil


Introduction/Background Cervical cancer is the third most common type of cancer among Brazilian women (excluding non-melanoma skin cancer), with 17,010 new cases expected per year between 2023 and 2025. Among women from Pernambuco, one state of the Brazilian Northeast, it is the second most frequent and lethal tumor, with the majority being diagnosed at an advanced stage. Cervical cancer treatment can lead to sexual dysfunction and to the emergence of menopausal symptoms, negatively impacting patients‘ quality of life.

Methodology To assess health-related quality of life, with an emphasis on sexual function in cervical cancer survivors, a descriptive, cross-sectional study involving 50 women aged 18 to 70 who completed oncological treatment for cervical cancer at IMIP, hospital that serves women in the public health system in Pernambuco, was conducted. Between March and August 2023, sexual function, overall quality of life in cancer patients and quality of life during menopause were assessed using Female Sexual Function Index (FSFI), Menopause Rating Scale (MRS) and EORTC QLQ-C30 questionnaires. Data analysis was conducted using the R statistical program.

Results Among interviewed patients, the average FSFI score was 20.49±4.2, with the lowest score in ‘desire’ and the highest in ‘orgasm.’ The average overall quality of life was 66.7±20.89, with better outcomes in ‘role functioning’ and ‘physical function’ and worse in ‘emotional function’. Common symptoms included ‘insomnia’ and ‘pain’. Regarding menopausal symptoms, psychological symptoms were prominent, with a higher average MRS score in sexually active women with dysfunction and lower in those without dysfunction.

Conclusion The analysis reveals that sexual dysfunction, particularly in ‘desire’ and ‘arousal’, is influenced by post-treatment body image. Furthermore, ‘satisfaction’ is not solely dependent on orgasm. Women post-cancer face emotional challenges, with an interrelation between menopausal symptoms and sexual dysfunction. A comprehensive approach is crucial.

Disclosures The authors have no conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.